For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Nicox Ophthalmics, Inc.

USPTO Granted Patents = 13

% Expired Patents = 7.7

EPO Patents = 7

Forward Citations = 16

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Mark Barry Abelson (6 out of 19 patents)

Paul Gomes (6 out of 9 patents)

Jackie Nice (6 out of 9 patents)

4. Matthew Jonathan Chapin (6 out of 10 patents)

5. George Edward Minno (6 out of 18 patents)

6. Shikha P Barman (5 out of 30 patents)

7. Thomas Cavanagh (5 out of 6 patents)

8. Tian Hao (5 out of 5 patents)

9. Thomas Bovard Leland (5 out of 5 patents)

10. Ritesh Vasudevan Thekkedath (4 out of 6 patents)

11. Jean-Michel Bukowski (2 out of 2 patents)

12. Akshay Nadkarni (2 out of 2 patents)

13. José L Boyer (2 out of 19 patents)

14. Brigitte Duquesroix-Chakroun (2 out of 4 patents)

15. Tomas Navratil (2 out of 11 patents)

13 patents: Sort by Forward Citations

1. 12622872 - Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions (2026-05-12),

2. 11918573 - Ophthalmic formulations of cetirizine and methods of use (2024-03-05),

3. 11814408 - Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof (2023-11-14),

4. 11617749 - Ophthalmic formulations of cetirizine and methods of use (2023-04-04),

5. 11406596 - Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions (2022-08-09),

6. 10987352 - Ophthalmic formulations of cetirizine and methods of use (2021-04-27),

7. 10954263 - Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof (2021-03-23),

8. 10675279 - Ophthalmic formulations of cetirizine and methods of use (2020-06-09),

9. 10174071 - Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof (2019-01-08),

10. 9993471 - Ophthalmic formulations of cetirizine and methods of use (2018-06-12),

11. 9822142 - Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof (2017-11-21),

12. 9815865 - Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof (2017-11-14),

13. 9750684 - Ophthalmic formulations of cetirizine and methods of use (2017-09-05),

Company Overview

Nicox Ophthalmics, Inc. is a biopharmaceutical company based in Durham, North Carolina, specializing in the development of innovative therapies for ocular diseases. The company focuses on advancing its proprietary drug candidates aimed at addressing unmet medical needs in the field of ophthalmology. With a commitment to improving patient outcomes, Nicox leverages its expertise in drug development and clinical research to create effective solutions for various eye conditions, enhancing the quality of life for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#64 in Durham, NC

#526 in North Carolina

#23,854 in US

#45,081 in the World

Durham, NC, United States of America

Nicox Ophthalmics, Inc.

Forward Citations = 16

17 inventors:

Mark Barry Abelson (6 out of 19 patents)

Paul Gomes (6 out of 9 patents)

Jackie Nice (6 out of 9 patents)

4. Matthew Jonathan Chapin (6 out of 10 patents)

5. George Edward Minno (6 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nicox Ophthalmics, Inc.. Retrieved from https://idiyas.com/company/nicox-ophthalmics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…